Autophagy and VSMC migration

自噬和 VSMC 迁移

基本信息

  • 批准号:
    9251904
  • 负责人:
  • 金额:
    $ 67.56万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-04-01 至 2020-02-28
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): In response to pro-atherosclerotic factors such as oxidized lipids, or to therapeutic interventions such as angioplasty, stents, or bypass surgery, vascular smooth muscle cells (VSMC) migrate to the intima, resulting in intimal hyperplasia, restenosis, graft failure, or atherosclerosis. Understanding the mechanisms involved in VSMC migration has been a major focus of biomedical research. Our exciting preliminary data show that in response to or wire-mediated carotid artery injury, increased expression of autophagy-related (Atg) proteins is associated with increased VSMC migration and intimal hyperplasia. Pharmacological and genetic suppression of autophagy inhibits VSMC migration. Mechanistically, suppression of vascular autophagy leads to the accumulation of amino acid synthesis protein 5 (GCN5), a ubiquitous histone acetyltransferase (HAT) that promotes transcriptional activation. Furthermore, we found that GCN5 accumulation is associated with increased α-tubulin acetylation, microtubule stabilization, and inhibition of VSMC migration. The central hypothesis is that autophagy-dependent degradation of GCN5 promotes VSMC migration via inhibition of α-tubulin acetylation. This hypothesis will be tested using gain-/lossof-function strategies in both animal models and cultured cells. Aim 1 will determine the role of autophagy in regulating VSMC migration in response to vascular injury in vivo by characterizing the spatial and temporal dynamics of vascular autophagy, VSMC migration, and neointimal hyperplasia using smMHC/eGFP transgenic mice, determining whether autophagy deficiency inhibits VSMC migration and neointimal formation in response to carotid ligation and/or vascular injury using Beclin1 heterozygous mice (beclin1+/-), and examining whether enhanced VSMC autophagy promotes VSMC migration and exacerbates neointimal hyperplasia and atherosclerosis in response to vascular injury in Atg7 SMC-specific transgenic mice (Atg-TG). In addition, the role of autophagy in regulating VSMC migration will be determined using gain- and loss-of-function approaches in cultured aortic rings and VSMCs. Aim 2 is to delineate the mechanism by which autophagy promotes VSMC migration. By test the hypothesis that autophagy promotes VSMC migration by enhancing GCN5 degradation and reducing α-tubulin acetylation. The proposed study will characterize the molecular mechanism by which autophagy degrades GCN5 in VSMCs, examine whether GCN5 acetylates α-tubulin and stabilizes microtubules, and determine whether autophagy suppression inhibits VSMC migration by increasing GCN5-mediated acetylation of α-tubulin in beclin+/- mice of wire-mediated carotid artery injury, carotid ligation, and atherosclerosis, and Apoe-/-/beclin1+/- mice fed with a high-ft diet.
 描述(由适用提供):响应诸如氧化的脂质等促动肌肉因子,或治疗性干预措施,例如血管成形术,支架或旁路手术,血管平滑肌细胞(VSMC)迁移到内膜,导致内膜,内膜增生,再融化,移植物,移植物,或Atherosssis。了解VSMC迁移涉及的机制一直是生物医学研究的主要重点。我们令人兴奋的初步数据表明,在响应或电线介导的颈动脉损伤时,自噬相关(ATG)蛋白的表达增加与VSMC迁移和内膜增生的增加有关。自噬的药理和遗传抑制抑制VSMC迁移。从机械上讲,血管自噬的抑制会导致氨基酸合成蛋白5(GCN5)的积累,这是一种无处不在的组蛋白乙酰转移酶(HAT),可促进转录激活。此外,我们发现GCN5的积累与α-微管蛋白乙酰化,微管稳定和VSMC迁移的抑制有关。中心假设是GCN5的自噬依赖性降解通过抑制α-微管蛋白乙酰化促进VSMC迁移。该假设将在动物模型和培养细胞中使用增益/丧失功能策略进行检验。 Aim 1 will determine the role of autophagy in controlling VSMC migration in response to vascular injury in vivo by characterizing the spatial and temporary dynamics of vascular autophagy, VSMC migration, and neointimal hyperplasia using smMHC/eGFP transgenic mice, determining whether autophagy deficiency inhibits VSMC migration and neointimal formation in response to carotid ligation使用Beclin1杂合小鼠(Beclin1 +/-)使用血管损伤,并检查增强的VSMC自噬是否促进了VSMC迁移,并加剧了ATG7 SMC SMC特异性转基因小鼠(ATGG-TG)的血管损伤的新膜增生和动脉粥样硬化。此外,将使用培养的主动脉环和VSMC中的功能丧失方法来确定自噬在确定VSMC迁移中的作用。目的2是描述自噬促进VSMC迁移的机制。通过测试自噬通过增强GCN5降解并减少α-微管蛋白乙酰化来促进VSMC迁移的假设。 The proposed study will characterize the molecular mechanism by which autophagy degrades GCN5 in VSMCs, examin whether GCN5 acetylates α-tubulin and stabilizes microtubulins, and determine whether autophagy suppression inhibits VSMC migration by increasing GCN5-mediated acetylation of α-tubulin in beclin+/- mice of wire-mediated carotid artery损伤,颈动脉连接和动脉粥样硬化,以及用高FFT饮食喂养的APOE - / - /beclin1 +/-小鼠。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Zhonglin Xie其他文献

Zhonglin Xie的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Zhonglin Xie', 18)}}的其他基金

SNRK in ischemic vascular diseases
SNRK 在缺血性血管疾病中的作用
  • 批准号:
    10411882
  • 财政年份:
    2018
  • 资助金额:
    $ 67.56万
  • 项目类别:
SNRK in ischemic vascular diseases
SNRK 在缺血性血管疾病中的作用
  • 批准号:
    9882513
  • 财政年份:
    2018
  • 资助金额:
    $ 67.56万
  • 项目类别:
FUNDC1 and diabetic cardiomyopathy
FUNDC1 与糖尿病心肌病
  • 批准号:
    9332944
  • 财政年份:
    2017
  • 资助金额:
    $ 67.56万
  • 项目类别:
Suppression of Autophagy-Dependent Clearance Mitochondria in Type 2 Diabetes
2 型糖尿病中自噬依赖性清除线粒体的抑制
  • 批准号:
    9032528
  • 财政年份:
    2015
  • 资助金额:
    $ 67.56万
  • 项目类别:
OKHSC COBRE: ACTIVATION OF AMPK PROTECTS AGAINST DIABETIC VASCULAR COMPLICATIONS
OKHSC COBRE:激活 AMPK 可预防糖尿病血管并发症
  • 批准号:
    8360279
  • 财政年份:
    2011
  • 资助金额:
    $ 67.56万
  • 项目类别:
OKHSC COBRE: ACTIVATION OF AMPK PROTECTS AGAINST DIABETIC VASCULAR COMPLICATIONS
OKHSC COBRE:激活 AMPK 可预防糖尿病血管并发症
  • 批准号:
    8167970
  • 财政年份:
    2010
  • 资助金额:
    $ 67.56万
  • 项目类别:
OKHSC COBRE: ACTIVATION OF AMPK PROTECTS AGAINST DIABETIC VASCULAR COMPLICATIONS
OKHSC COBRE:激活 AMPK 可预防糖尿病血管并发症
  • 批准号:
    7959772
  • 财政年份:
    2009
  • 资助金额:
    $ 67.56万
  • 项目类别:
OKHSC COBRE: ACTIVATION OF AMPK PROTECTS AGAINST DIABETIC VASCULAR COMPLICATIONS
OKHSC COBRE:激活 AMPK 可预防糖尿病血管并发症
  • 批准号:
    7721017
  • 财政年份:
    2008
  • 资助金额:
    $ 67.56万
  • 项目类别:

相似国自然基金

肝胆肿瘤治疗性溶瘤腺病毒疫苗的研制及其临床前应用性探索
  • 批准号:
    82303776
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
PD-1/PD-L1信号促CD21-B细胞BCR髓外二次编辑降低自身反应性在儿童腺病毒肺炎中的作用机制研究
  • 批准号:
    82370015
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
基于sIgA的V(D)J结构多样性探索腺病毒载体鼻喷新冠奥密克戎疫苗诱导的呼吸道粘膜免疫原性特征
  • 批准号:
    82302607
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
禽腺病毒血清11型反向遗传平台的建立与毒株间致病性差异机制探究
  • 批准号:
    32372997
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
CD46和DSG2双受体在人B组腺病毒感染与致病中的协同作用和机制研究
  • 批准号:
    32370155
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目

相似海外基金

Mechanisms linking the Branched-Chain alpha-Keto Acid regulatory network to the pathogenesis of NASH
支链 α-酮酸调节网络与 NASH 发病机制的联系机制
  • 批准号:
    10628663
  • 财政年份:
    2023
  • 资助金额:
    $ 67.56万
  • 项目类别:
Glutaredoxin, Glutathione Metabolism and Lung Cancer
谷氧还蛋白、谷胱甘肽代谢与肺癌
  • 批准号:
    10657945
  • 财政年份:
    2023
  • 资助金额:
    $ 67.56万
  • 项目类别:
Molecular and functional investigation of the role of HLA-F in immune regulation
HLA-F在免疫调节中作用的分子和功能研究
  • 批准号:
    10503676
  • 财政年份:
    2022
  • 资助金额:
    $ 67.56万
  • 项目类别:
Molecular and functional investigation of the role of HLA-F in immune regulation
HLA-F在免疫调节中作用的分子和功能研究
  • 批准号:
    10636894
  • 财政年份:
    2022
  • 资助金额:
    $ 67.56万
  • 项目类别:
Protein Conjugation For Antigen-Specific Treatment Of Thyroid Autoimmune Diseases
用于甲状腺自身免疫性疾病抗原特异性治疗的蛋白质缀合
  • 批准号:
    10385632
  • 财政年份:
    2021
  • 资助金额:
    $ 67.56万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了